4D Molecular Therapeutics, Inc. Balance Sheet

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Accumulated Depreciation 2.62M3.84M5.33M7.73M11.93M16.59M
Assets
Assets 58.23M288.33M353.49M261.85M339.89M560.38M
Current Assets
Cash & Equivalents 49.65M276.73M153.00M52.35M249.11M149.34M
Receivables - Net 0.98M1.49M0.05M
Receivables - Other 0.15M0.70M0.70M
Receivables 1.13M1.49M0.75M
Prepaid Assets 1.88M4.44M8.46M6.96M8.36M10.05M
Current Assets 52.51M282.66M256.28M220.51M296.59M434.93M
Non-Current Assets
Property, Plant & Equipment (Net) 5.05M5.07M14.39M22.26M20.13M19.53M
Long-Term Investments 67.65M4.91M10.95M80.58M
Other Non-Current Assets 0.68M0.60M0.60M1.08M0.68M4.26M
Non-Current Assets 5.73M5.67M97.21M41.34M43.30M125.45M
Liabilities
Current Liabilities
Accounts Payables 1.74M1.79M4.76M3.32M3.52M4.39M
Payables 1.74M1.79M4.76M3.32M3.52M4.39M
Accumulated Expenses 5.35M8.37M7.74M8.87M12.01M18.87M
Other Accumulated Expenses 0.48M0.49M1.77M0.38M0.10M0.11M
Current Leases 1.23M2.65M3.15M5.64M
Current Deferred Revenue 19.47M19.81M5.09M1.96M0.27M0.26M
Total Current Liabilities 12.96M16.74M16.34M15.73M18.95M29.15M
Non-Current Liabilities
Non-Current Deffered Revenue 13.60M13.23M2.49M1.08M0.97M1.06M
Preferred Stock Liabilities 102.98M
Operating Leases 15.22M13.47M11.52M18.97M
Other Non-Current Liabilities 1.56M1.85M0.21M0.21M0.37M0.41M
Total Non-Current Liabilities 26.66M30.09M34.17M30.30M31.69M49.37M
Liabilities
Total Liabilities 28.22M31.94M34.38M30.51M32.06M49.78M
Shareholder's Equity
Common Equity -72.97M256.39M319.11M231.34M307.83M510.61M
Shareholder's Equity -72.97M256.39M319.11M231.34M307.83M510.61M
Liabilities and Shareholders Equity 58.23M288.33M353.49M261.85M339.89M560.38M
Retained Earnings -79.03M-135.68M-207.00M-314.49M-415.33M-576.20M
Treasury Shares 0.18M0.36M
Shares Outstanding 5.18M26.68M32.22M32.63M43.08M45.79M